NANO MRNA Co.,Ltd. (TYO:4571)
Japan
· Delayed Price · Currency is JPY 146.00
-4.00 (-2.67%)
Jun 24, 2025, 3:30 PM JST
NANO MRNA Revenue
In the fiscal year ending March 31, 2025, NANO MRNA had annual revenue of 108.00M JPY, down -20.00%. NANO MRNA had revenue of 25.00M in the quarter ending March 31, 2025, a decrease of -19.35%.
Revenue
108.00M
Revenue Growth
-20.00%
P/S Ratio
95.43
Revenue / Employee
6.00M
Employees
18
Market Cap
10.31B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.30B |